object
investig
characterist
rule
hematolog
chang
patient
explor
possibl
identifi
moder
sever
patient
use
convent
hematolog
paramet
combin
paramet
clinic
data
moder
sever
type
patient
infect
jingzhou
central
hospit
januari
februari
collect
epidemiolog
index
clinic
symptom
laboratori
test
result
patient
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
retrospect
analyz
paramet
signific
differ
two
group
analyz
combin
paramet
best
diagnost
perform
select
use
lda
method
patient
moder
sever
case
male
femal
age
year
common
clinic
symptom
fever
dri
cough
diseas
progress
wbc
neu
nlr
plr
rdwcv
rdwsd
paramet
sever
group
significantli
higher
moder
group
p
meanwhil
lym
eo
hfc
rbc
hgb
hct
paramet
sever
group
significantli
lower
moder
group
p
nlr
auc
best
cutoff
valu
sensit
specif
respect
plr
auc
best
cutoff
sensit
specif
respect
combin
paramet
nlr
rdwsd
best
diagnost
effici
auc
cutoff
valu
sensit
specif
respect
follow
fit
paramet
nlr
rdwcv
auc
cutoff
valu
sensit
specif
distinguish
sever
type
moder
case
respect
combin
paramet
nlr
rdwsd
best
hematolog
index
help
clinician
predict
sever
patient
use
use
indic
help
prevent
control
epidem
take
test
everi
day
everi
two
day
play
import
role
sever
case
identif
provid
clinician
auxiliari
diagnost
inform
diagnosi
treatment
guidelin
trial
version
clearli
point
total
number
peripher
white
blood
cell
normal
decreas
lymphocyt
count
reduc
earli
stage
onset
li
et
al
conduct
descript
predict
studi
found
lymphocyt
percentag
lym
invers
relat
sever
prognosi
patient
could
use
predict
sever
prognosi
patient
indic
chang
peripher
blood
occur
patient
infect
chang
potenti
provid
clue
guidanc
diagnosi
treatment
prognosi
patient
newest
hematolog
analyz
mindray
medic
intern
co
ltd
shenzhen
china
use
principl
nucleic
acid
fluoresc
stain
flow
cytometri
detect
white
blood
cell
red
blood
cell
platelet
peripher
venou
blood
three
dimens
blood
cell
identifi
quantit
analyz
accord
volum
cell
complex
content
well
nucleic
acid
content
addit
provid
routin
hematolog
paramet
also
quantit
detect
immatur
granulocyt
nucleat
red
blood
cell
naiv
platelet
well
blast
cell
base
analysi
result
studi
intend
discov
characterist
chang
peripher
blood
explor
valu
hematolog
routin
paramet
diagnosi
treatment
patient
studi
focus
identif
critic
patient
use
hematolog
routin
paramet
order
explor
valu
hematolog
routin
paramet
retrospect
analyz
epidemiolog
laboratori
test
result
moder
sever
case
differ
differ
group
found
routin
laboratori
test
analyz
order
provid
valuabl
help
clinician
diagnos
treat
diseas
effect
medic
colleg
yangtz
univers
jingzhou
hubei
provinc
peopl
republ
china
among
patient
case
moder
case
sever
type
patient
confirm
viral
detect
use
novel
coronaviru
nucleic
acid
detect
kit
fluoresc
pcr
method
shanghai
biogerm
medic
biotechnolog
co
ltd
patient
rule
coinfect
respiratori
viru
includ
respiratori
syncyti
viru
adenoviru
influenza
viru
influenza
viru
b
parainfluenza
viru
chlamydia
pneumonia
legionella
pneumonia
mycoplasma
pneumonia
use
serolog
method
case
diagnos
classifi
accord
diagnosi
treatment
guidelin
trial
sixth
edit
clinic
standard
identif
moder
sever
patient
follow
moder
fever
respiratori
track
symptom
pneumonia
imag
sever
follow
condit
besid
symptom
sign
moder
respiratori
distress
rr
timesminut
b
oxygen
satur
rest
state
c
arteri
blood
oxygen
partial
pressur
oxygen
concentr
lung
imag
progress
short
term
epidemiolog
characterist
inform
includ
recent
exposur
histori
travel
histori
contact
patient
fever
respiratori
symptom
citi
hubei
provinc
confirm
case
within
two
week
basic
inform
gender
age
clinic
symptom
sign
collect
admiss
record
laboratori
data
includ
complet
blood
count
mindray
serum
biochemistri
coagul
test
collect
laboratori
inform
system
li
studi
total
result
detect
mindray
hematolog
analyz
biochemistri
well
coagul
test
collect
patient
infect
jan
feb
laboratori
test
result
divid
two
group
base
sourc
sampl
moder
sever
patient
retrospect
analysi
compar
analysi
perform
studi
spss
statist
softwar
version
use
data
statist
map
age
repres
median
rang
other
demograph
clinic
characterist
express
frequenc
percentag
signific
test
chi
squar
fisher
exact
test
quantiz
variabl
blood
paramet
express
mean
standard
deviat
signific
two
group
test
student
ttest
p
consid
statist
signific
statist
analys
linear
discrimin
analysi
lda
employ
perform
linear
combin
two
paramet
extract
best
data
featur
distinguish
moder
sever
case
patient
diagnost
valu
valuabl
paramet
differenti
mild
sever
case
patient
assess
receiv
oper
characterist
roc
area
roc
curv
auc
combin
paramet
analyz
use
lda
lda
supervis
learn
model
also
known
fisher
linear
discrimin
fld
principl
lda
multiparamet
linear
combin
highdimension
pattern
sampl
compos
multiparamet
project
optim
discrimin
vector
space
achiev
effect
extract
classif
inform
compress
featur
space
dimens
new
subspac
largest
interclass
distanc
smallest
intraclass
distanc
pattern
best
separ
space
therefor
effect
featur
extract
method
fortyf
confirm
patient
divid
moder
case
sever
case
infect
group
tabl
signific
differ
median
age
two
group
p
patient
male
femal
also
signific
differ
gender
composit
two
group
patient
p
case
total
patient
wuhan
within
week
hospit
these
patient
moder
patient
sever
patient
signific
differ
wuhan
contact
histori
two
group
p
patient
ever
visit
south
china
seafood
market
three
patient
moder
patient
worth
note
patient
hypertensionbas
diseas
sever
patient
patient
case
fever
dri
cough
fatigu
chill
myalgia
respect
signific
differ
two
group
p
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
total
venou
blood
sampl
anticoagul
collect
patient
jan
feb
laboratori
among
venou
blood
sampl
collect
moder
patient
sever
patient
hematolog
characterist
sampl
two
group
present
tabl
diseas
progress
wbc
neu
nlr
plr
rdwcv
rdwsd
paramet
sever
group
significantli
higher
moder
group
p
meanwhil
lym
eo
hfc
rbc
hgb
hct
paramet
sever
group
significantli
lower
moder
group
p
boxplot
signific
paramet
present
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
boxplot
provid
student
ttest
employ
compar
differ
cbc
paramet
moder
sever
case
group
p
biochem
coagul
test
result
patient
jan
feb
laboratori
present
tabl
biochem
coagul
test
sampl
usual
collect
test
everi
day
diseas
progress
dbil
glo
bun
cr
cy
c
ck
mb
ldh
fbg
sever
group
significantli
higher
moder
group
p
meanwhil
alb
na
ca
sever
group
significantli
lower
moder
group
p
signific
differ
coagul
test
result
two
group
p
roc
curv
use
analyz
hematolog
paramet
signific
differ
two
group
paramet
auc
statist
signific
p
auc
exclud
next
analyz
diagnost
efficaci
hematolog
paramet
respect
combin
paramet
fit
lda
method
also
use
diagnost
efficaci
analysi
differenti
sever
moder
group
among
paramet
said
found
combin
paramet
nlr
rdwsd
gener
linear
fit
nlr
rdwsd
accord
formula
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
clinician
judg
patient
condit
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
differenti
diagnosi
moder
sever
patient
use
differ
paramet
posit
sampl
blood
routin
result
sever
patient
neg
sampl
blood
routin
result
moder
patient
figur
roc
plot
use
singl
paramet
identifi
sever
moder
patient
figur
b
roc
plot
use
combin
paramet
nlr
rdwsd
nlr
rdwcv
identifi
patient
figur
c
boxplot
use
combin
paramet
comparison
two
group
figur
e
recommend
manag
strategi
patient
meanwhil
use
cutoff
valu
best
singleparamet
nlr
combin
paramet
nlr
rdwsd
judgment
threshold
list
fourfold
tabl
tabl
tabl
calcul
diagnost
item
found
combin
paramet
nlr
rdwsd
better
diagnost
perform
diagnost
accuraci
rate
better
predict
valu
likelihood
ratio
singl
paramet
nlr
although
current
epidemiolog
situat
show
contagi
sarscov
merscov
cluster
outbreak
among
peopl
lethal
less
sever
outbreak
also
high
mortal
rate
earli
stage
area
first
confirm
infect
case
admit
hospit
wuhan
decemb
januari
show
patient
mortal
rate
begin
outbreak
patient
requir
icu
monitor
treatment
latest
data
publish
therefor
mani
expert
remind
us
may
coexist
human
long
time
potenti
infect
risk
need
special
attent
increas
number
asymptomat
infect
marc
lipsitch
professor
epidemiolog
harvard
univers
predict
would
infect
peopl
worldwid
therefor
track
screen
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
suspect
case
import
patient
symptom
fever
dri
cough
earli
stage
possibl
patient
develop
sever
critic
case
current
epidem
situat
china
appear
control
global
epidem
outsid
china
still
earli
middl
stage
outbreak
neither
detect
capabl
viral
nucleic
acid
kit
popular
rate
imag
ct
support
largescal
screen
popul
convent
peripher
hematolog
test
method
characterist
chang
prompt
infect
patient
especi
sever
infect
help
clinician
interven
earli
reduc
mortal
patient
reliev
pressur
epidem
studi
review
epidemiolog
underli
diseas
sign
well
chang
blood
routin
biochem
coagul
test
result
patient
infect
differ
diseas
sever
jingzhou
hubei
provinc
china
signific
differ
seen
epidemiolog
find
two
group
p
underli
diseas
patient
hypertens
sever
type
patient
fever
dri
cough
fatigu
chill
myalgia
fever
dri
cough
still
common
symptom
patient
although
mani
case
review
trend
similar
report
literatur
comparison
hematolog
paramet
wbc
neu
nlr
plr
rdwcv
rdwsd
sever
group
significantli
higher
moder
group
p
meanwhil
lym
eo
hfc
rbc
hgb
hct
sever
group
significantli
lower
moder
group
p
among
wbc
neu
significantli
higher
sever
patient
may
relat
persist
infect
prolong
hypoxia
lead
compensatori
hyperplasia
bone
marrow
releas
granulocyt
result
consist
find
chen
et
al
signific
lymphopenia
sever
group
may
caus
continu
invad
lymphocyt
prolifer
caus
lymphocyt
die
even
becom
deplet
reach
spleen
immun
organ
lymphopenia
report
mani
scholar
phenomenon
also
seen
sarscov
merscov
infect
trend
lym
found
consist
descript
mention
diagnosi
treatment
guidelin
trial
version
studi
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
copyright
holder
preprint
http
doi
medrxiv
preprint
lymphopenia
reach
signific
differ
platelet
count
moder
sever
patient
p
sar
broke
guangzhou
china
first
report
blood
cell
count
normal
decreas
lymphocyt
eosinophil
decreas
monocyt
increas
thrombocyt
decreas
patient
similarli
report
hong
kong
indic
patient
lymphopenia
thrombocytopenia
thrombocytosi
hemoglobin
decreas
gl
autopsi
show
decreas
lymphocyt
haematolymphoid
organ
multivari
analysi
show
old
age
high
concentr
ldh
independ
predictor
poor
prognosi
lymphopenia
lymphocyt
subpopul
deplet
may
relat
diseas
result
studi
similar
report
lymphocyt
platelet
also
import
indic
monitor
peak
viral
load
immunopatholog
damag
palli
treatment
lung
diseas
abidol
combin
lopinavir
ritonavir
studi
ratio
neutrophil
lymphocyt
nlr
ratio
platelet
lymphocyt
plr
sever
group
show
significantli
higher
p
show
best
singl
paramet
differenti
diagnost
efficaci
nlr
auc
plr
auc
liu
et
al
beij
ditan
hospit
capit
medic
univers
beij
china
also
suggest
nlr
help
earli
detect
sever
patient
nad
high
predict
accuraci
auc
consist
conclus
articl
addit
studi
found
red
blood
cell
paramet
rbc
hgb
hct
significantli
reduc
sever
group
morpholog
paramet
rdwcv
rdwsd
significantli
higher
sever
group
moder
patient
may
result
immun
damag
lead
suppress
bone
marrow
lead
gradual
increas
anemia
caus
compensatori
hyperplasia
erythroid
cell
line
larg
number
immatur
red
blood
cell
releas
peripher
blood
activ
red
blood
cell
apoptosi
peripher
phagocytosi
therefor
result
increas
red
blood
cell
distribut
width
comparison
significantli
lower
moder
group
p
also
consist
recent
report
scholar
accord
chang
trend
nlr
rdwsd
use
lda
carri
linearli
fit
differ
hematolog
paramet
develop
diagnosi
diseas
affect
two
mutual
mask
paramet
diagnost
perform
lower
one
paramet
use
exampl
one
paramet
high
sensit
high
specif
fit
two
differ
paramet
ax
c
w
one
combin
paramet
advantag
two
paramet
specif
sensit
time
effect
use
diagnosi
predict
diseas
studi
fit
analysi
differ
paramet
nlr
rdwsd
combin
paramet
select
best
indic
distinguish
moder
patient
sever
case
auc
diagnost
accuraci
rate
combin
paramet
help
clinician
prejudg
stage
patient
take
effect
treatment
measur
advanc
studi
singlecent
exploratori
retrospect
studi
includ
case
moder
sever
patient
respect
fever
dri
cough
common
symptom
age
distribut
mainli
year
old
pregnant
women
children
elder
asymptomat
patient
includ
studi
therefor
specif
applic
need
verifi
confirm
clinic
case
time
analyz
studi
prognosi
includ
case
howev
studi
suggest
may
possibl
find
potenti
sever
patient
routin
basic
hematolog
test
earli
stage
order
provid
patient
earli
clinic
intervent
reduc
patient
mortal
help
control
prevent
epidem
believ
studi
provid
refer
valu
research
epidem
prevent
countri
region
current
viru
begun
spread
global
clinic
effect
drug
vaccin
pass
clinic
trial
wide
safe
appli
inevit
patient
develop
sever
even
critic
patient
establish
effect
treatment
strategi
sever
critic
patient
depend
earli
diagnosi
ccbyncnd
intern
licens
made
avail
authorfund
grant
medrxiv
licens
display
preprint
perpetu
peerreview
copyright
holder
preprint
http
doi
medrxiv
preprint
earli
warn
diseas
progress
key
reduc
overal
mortal
patient
studi
found
combin
paramet
nlr
rdwsd
use
indic
distinguish
moder
patient
sever
case
auc
base
optim
cutoff
valu
diagnost
accuraci
good
posit
neg
likelihood
ratio
say
result
nlr
rdwsd
patient
exce
suggest
greater
possibl
patient
situat
like
get
wors
patient
like
sever
patient
result
nlr
rdwsd
less
suggest
patient
like
get
better
moder
patient
inform
help
clinician
predict
sever
diseas
classif
patient
take
effect
treatment
measur
advanc
carri
differenti
treatment
control
epidem
effect
